Rigel Pharmaceuticals (RIGL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer ...

Rigel will mail the definitive proxy statement/prospectus to shareholders of record as of the close of business on January 10, 2025. Rigel will hold its Extraordinary General Meeting (the ...

AUROUS Resources, the South African business that controls the historic Blyvooruitzicht mine, has received regulatory approval to merge with Rigel Resource Acquisition Group, a deal that would pave ...

Aurous Resources, the South African mining group that owns and operates the Blyvoor gold mine in Gauteng’s West Rand, today announced it has secured approval from the US Securities and Exchange ...

The K-drama When the Stars Gossip, which generated a lot of buzz for being the first Korean office drama and romantic series to take place in space, has been plagued with low ratings in South ...

This wide-field view of the sky around the bright star system Alpha Centauri was created from photographic images forming part of the Digitized Sky Survey 2. (Image credit: ESO/Digitized Sky ...

Melbourne Renegades vs Melbourne Stars Live Score: It’s a Wicket. Adam Zampa is out and Melbourne Renegades at 101/9 after 16.3 overs Melbourne Renegades vs Melbourne Stars Live Score ...

Clint Jordan Lopaka Nahooikaika Borge, 41, of Pahoa was arrested Thursday on a federal grand jury indictment that charges him with one count of engaging in a child exploitation enterprise. Read more ...

The Dallas Stars narrowly beat the Montreal Canadiens in 2-1 victory in the shootout. It was the Stars seventh-straight win and marked the longest winning streak of Peter DeBoer's tenure in Dallas.

Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...